Search bioRxiv⌕ Search

Biology subjects

Rigato, I.

Publications and source records attributed to Rigato, I..

2 recordsLinked to original sources

Rectangle: robust and scalable multiscale deconvolution informed by single-cell RNA sequencing data

Bulk RNA-seq enables effective profiling of large cohorts and complex experimental designs, but current single-cell-informed deconvolution methods incompletely resolve closely related cell phenotypes, do not scale efficiently to large single-cell datasets, or fail to account for cellular content not represented in the reference. Here, we present Rectangle, an scverse Python framework for single-cell-informed deconvolution of bulk RNA-seq data. Rectangle combines multiscale deconvolution, capturing cellular composition across multiple resolution levels, with explicit modeling of unknown cellular content. In a diverse, cross-method benchmark, Rectangle achieved consistently strong performance across all evaluated metrics, demonstrating high accuracy, high resolution, low spillover, strong scalability and efficiency, and robustness to unknown cellular content. By bridging the resolution of single-cell transcriptomics with the scale and cost-efficiency of bulk RNA-seq, Rectangle enables cell-type and cell-state profiling at scale, supporting population-scale cellular biomarker discovery and tracking of cellular dynamics in settings impractical for comprehensive single-cell sequencing.

bioinformatics↗

TET2 loss promotes premalignant survival and clonal selection in MYC-driven B cell lymphoma

The DNA demethylase ten-eleven translocation enzyme 2 (TET2) is frequently inactivated in hematologic malignancies, yet how its loss shapes oncogene-driven transformation remains unclear. Using a mouse model in which MYC is overexpressed in the B cell lineage, driving aggressive B cell lymphoma, we show that Tet2 loss increases lymphoma penetrance and biases disease toward an IgM immunophenotype. Established lymphomas are broadly similar across genotypes, suggesting that Tet2 loss exerts much of its effects before lymphoma onset. Accordingly, Tet2 loss expands a premalignant IgM B cell subset with reduced apoptotic sensitivity and an increased frequency of BCL2BIMhi cells. Consistently, Tet2 deficient IgM B cells persist better in in vitro cultures, show increased clonogenic survival, and exhibit clonal skewing. These findings support a model in which Tet2 loss heightens MYC-driven lymphoma penetrance by promoting the survival and selection of premalignant B cells under apoptotic stress.

cancer biology↗